TP53 and thyroid gland carcinoma: Overall, our analysis has confirmed that, even in patients with well-differentiated thyroid cancer, p53-Abs is significantly more frequent compared to patients without thyroid malignancy, and this relatively simple laboratory marker has some potential to improve diagnostics in this group.